Neurelis Announces Completion Of Dosing In Study Of Intranasal Diazepam

Links shared publicly online about this topic.

347
total visits

Neurelis Announces Completion Of Dosing In Study Of Intranasal Diazepam

Neurelis, Inc. announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulati

View full resource at medicalnewstoday.com

Tags: Anxiety Medication, Pharma, Valium, Pharmacokinetics

Most Recently Shared on April 22, 2011 at 10:05 am By:

MNT Clinical Trials

Neurelis Announces Completion Of Dosing In Study Of Intranasal Diazepam http://mnt.to/3TX3 #clinicaltrials

12 months ago...

Retweet

Favorite

Also Shared By:

MNT Pharma News

Neurelis completes dosing in intranasal diazepam formulation study

news-medical.net — “Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.” View full resource at news-medical.net